A Clinical Study to Evaluate the Efficacy and Satisfaction of Ultrasound Therapy Combined With SkinCeuticals A.G.E for Improving Facial Aging

Last updated: April 18, 2023
Sponsor: Yes Skin Medical Group
Overall Status: Active - Recruiting

Phase

N/A

Condition

Skin Aging

Treatment

N/A

Clinical Study ID

NCT05748470
WSong
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

A Prospective, Single-center, Single-blind, Randomized split-face, controlled trial will be conducted. The goal of this clinical trial is to evaluate the efficacy and satisfaction of ultrasound therapy combined with SkinCeuticals A.G.E in improving facial aging, and to explore the medical value of ultrasound therapy combined with SkinCeuticals A.G.E. Participants will be treated with ultrasound combined with SkinCeuticals A.G.E on one randomized side face and ultrasound combined with standard cream on the other side.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Chinese subjects aged 18-65 years inclusive;
  2. The subject 's facial skin is rough, flaccid, and lack of elasticity;
  3. Subjects with multiple facial fine lines (perioral/periocular/forehead, etc.), decreelines or puppet lines area with static fine lines trend, the lower part showed signsof loosening;
  4. Subjects who have consistent facial skin status on both sides and plan to receiveultrasound therapy;
  5. Subjects are willing to follow the requirements of the study protocol and complete thecorresponding procedures;
  6. Subjects understand the nature of the study and sign the informed consent form (ICF).

Exclusion

Exclusion Criteria:

  1. Subjects with contraindications to ultrasound treatment (such as malignant tumor,acute systemic infection, severe heart disease, bleeding tendency, etc.) orcontraindications to A.G.E use (or allergic to other skin care components);
  2. Subjects with facial skin diseases, infection, inflammation or allergic constitutionthat may affect the judgment of the test results;
  3. Subjects with hypertrophic scar or scar constitution;
  4. Receiving treatment of tightening medical treatment program (Thermage/Fotona 4D/ultrasound/microneedle, etc.) or planning to receive other tightening medicaltreatment program and drugs during this treatment in the past 3 months;
  5. Patients who have oral or topical cosmetic products that may affect the test resultswithin the past 2 weeks;
  6. Subjects who have participated in drug clinical trials or other trials within the past 30 days (or are participating in), or have used drugs affecting the test resultswithin 1 week;
  7. Female subjects who are pregnant, lactating or plan to become pregnant;
  8. Other subjects who are not suitable for participating in this study as assessed by theinvestigator.

Study Design

Total Participants: 50
Study Start date:
March 28, 2023
Estimated Completion Date:
October 30, 2023

Connect with a study center

  • Hang Zhou YesSkin Hospital

    Hangzhou,
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.